SUPN - Supernus Pharmaceuticals Inc. (SUPN) Q1 2024 Earnings Call Transcript
2024-05-08 20:28:08 ET
Supernus Pharmaceuticals, Inc. (SUPN)
Q1 2024 Earnings Conference Call
May 08, 2024 04:30 PM ET
Company Participants
Peter Vozzo - ICR Westwicke, Investor Relations
Jack Khattar - Chief Executive Officer
Tim Dec - Chief Financial Officer
Conference Call Participants
Andrew Tsai - Jefferies
Stacy Ku - TD Cowen
Jack Padovano - Stifel
Presentation
Operator
Good afternoon, and welcome to the Supernus Pharmaceuticals First Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Instructions will follow at that time. As a reminder, this conference call is being recorded.
I would now like to turn the conference over to Peter Vozzo of ICR Westwicke, Investor Relations representative, Supernus Pharmaceutical. You may now begin.
Peter Vozzo
Thank you, Mark. Good afternoon, everyone, and thank you for joining us today for Supernus Pharmaceuticals' first quarter 2024 financial results conference call. Today, after the close of the market, the company issued a press release announcing these results.
On the call with me today are Supernus' Chief Executive Officer, Jack Khattar; and Chief Financial Officer, Tim Dec. Today's call is being made available via the Investor Relations section of the company's website at ir.supernus.com....
Supernus Pharmaceuticals, Inc. (SUPN) Q1 2024 Earnings Call Transcript